Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
Blue curve MMWR spacer

The content on this page is being archived for historic and reference purposes only. The content, links, and pdfs are no longer maintained and might be outdated.

Addendum: Vol. 43, No. 22

In the article "Birth Outcomes Following Zidovudine Therapy in Pregnant Women," on page 415 the second sentence of the first full paragraph should read "In January 1993, the Zidovudine in Pregnancy Registry was expanded to include zalcitabine and became the Antiretroviral Pregnancy Registry jointly managed by Burroughs Wellcome Co. and Hoffmann-LaRoche Inc."

Any pregnancies exposed to either zidovudine or zalcitabine should be reported to the registry, telephone (800) 722-9292, extension 8465, within the United States and (919) 315-8465 for registrations from outside the United States.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to

Page converted: 09/19/98


Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A


Department of Health
and Human Services

This page last reviewed 5/2/01